AbbVie
ABBV
#26
Rank
โ‚น35.792 T
Marketcap
โ‚น20,251
Share price
1.54%
Change (1 day)
41.22%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): โ‚น143.94 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น59.64 Billion. In 2024 the company made an earning of โ‚น332.61 Billion a decrease over its 2023 earnings that were of โ‚น559.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น143.94 B-56.72%
2024 โ‚น332.61 B-40.54%
2023 โ‚น559.43 B-53.62%
2022 โ‚น1.206 T3.76%
2021 โ‚น1.162 T282.25%
2020 โ‚น304.15 B-59.67%
2019 โ‚น754.20 B62.13%
2018 โ‚น465.17 B-32.74%
2017 โ‚น691.63 B-1.99%
2016 โ‚น705.68 B18.65%
2015 โ‚น594.78 B180.5%
2014 โ‚น212.04 B-55.57%
2013 โ‚น477.26 B-6.86%
2012 โ‚น512.43 B56.05%
2011 โ‚น328.36 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.060 T 613.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น719.02 B 383.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.014 T 1,255.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น737.91 B 396.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น884.88 B 495.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น170.42 B 14.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น834.48 B 461.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
โ‚น1.171 T 688.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น52.20 B-64.87%๐Ÿ‡บ๐Ÿ‡ธ USA